1 1600 119 MEDIYOGA AS A PART OF A SELF-MANAGEMENT PROGRAMME AMONG PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION - A RANDOMISED STUDY. BACKGROUND: PAROXYSMAL ATRIAL FIBRILLATION IS ASSOCIATED WITH IMPAIRED HEALTH-RELATED QUALITY OF LIFE. YOGA HAS BEEN SUGGESTED TO IMPROVE HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH HEART FAILURE AND HYPERTENSION. AIM: THE AIM OF THE STUDY WAS TO EVALUATE THE EFFECTS OF MEDIYOGA, IN RESPECT OF HEALTH-RELATED QUALITY OF LIFE, BLOOD PRESSURE, HEART RATE, AS WELL AS N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE, AMONG PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION, COMPARED WITH STANDARD THERAPY OR RELAXATION. METHODS: PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION, N=132, WERE STRATIFIED FOR GENDER AND RANDOMISED TO MEDIYOGA, A RELAXATION GROUP OR A CONTROL GROUP, 44 PATIENTS PER GROUP WITH A 12-WEEK FOLLOW-UP. HEALTH-RELATED QUALITY OF LIFE, BLOOD PRESSURE, HEART RATE AND N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE WERE ASSESSED. RESULTS: AFTER 12 WEEKS, THERE WERE NO DIFFERENCES IN HEALTH-RELATED QUALITY OF LIFE BETWEEN THE GROUPS. THERE WERE IMPROVEMENTS IN SHORT-FORM HEALTH SURVEY BODILY PAIN, GENERAL HEALTH, SOCIAL FUNCTION, MENTAL HEALTH AND MENTAL COMPONENT SUMMARY SCORES WITHIN THE MEDIYOGA GROUP (P=0.014, P=0.037, P=0.029, P=0.030, P=0.019, RESPECTIVELY). NO CHANGE WAS SEEN IN THE RELAXATION AND CONTROL GROUPS. SYSTOLIC BLOOD PRESSURE DECREASED IN THE MEDIYOGA GROUP (134+/-18 TO 127+/-13) COMPARED WITH THE CONTROL GROUP (126+/-17 TO 127+/-15, P=0.041); NO DIFFERENCE COMPARED WITH THE RELAXATION GROUP (131+/-17 TO 125+/-12). DIASTOLIC BLOOD PRESSURE DECREASED IN THE MEDIYOGA GROUP (79+/-9 TO 74 +/-9) COMPARED WITH THE CONTROL GROUP (76+/-9 TO 79+/-8, P=0.005); NO DIFFERENCE COMPARED WITH THE RELAXATION GROUP (76+/-9 TO 77+/-8). THERE WERE NO DIFFERENCES IN HEART RATE AND N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE BETWEEN THE GROUPS AFTER 12 WEEKS. CONCLUSIONS: MEDIYOGA IMPROVES HEALTH-RELATED QUALITY OF LIFE AND DECREASES BLOOD PRESSURE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION. MEDIYOGA MAY BE USED AS A PART OF A SELF-MANAGEMENT PROGRAMME AMONG PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION. 2020 2 185 39 A RANDOMIZED CONTROLLED TRIAL TO STUDY THE EFFECT OF YOGA THERAPY ON CARDIAC FUNCTION AND N TERMINAL PRO BNP IN HEART FAILURE. AIMS: THE PURPOSE OF THIS STUDY WAS TO EVALUATE WHETHER YOGA TRAINING IN ADDITION TO STANDARD MEDICAL THERAPY CAN IMPROVE CARDIAC FUNCTION AND REDUCE N TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE (NT PRO BNP) IN HEART FAILURE (HF). METHODS: 130 PATIENTS WERE RECRUITED AND RANDOMIZED INTO TWO GROUPS: CONTROL GROUP (CG) (N = 65), YOGA GROUP (YG). IN YG, 44 PATIENTS AND IN CG, 48 PATIENTS COMPLETED THE STUDY. CARDIAC FUNCTION USING LEFT VENTRICULAR EJECTION FRACTION (LVEF), MYOCARDIAL PERFORMANCE INDEX (TEI INDEX), AND NT PRO BNP, A BIOMARKER OF HF, WAS ASSESSED AT BASELINE AND AFTER 12 WEEKS. RESULT: IMPROVEMENT IN LVEF, TEI INDEX, AND NT PRO BNP WERE STATISTICALLY SIGNIFICANT IN BOTH THE GROUPS. FURTHERMORE, WHEN THE CHANGES IN BEFORE AND AFTER 12 WEEKS WERE IN PERCENTAGE, LVEF INCREASED 36.88% IN THE YG AND 16.9% IN THE CG, TEI INDEX WAS REDUCED 27.87% IN THE YG AND 2.79% IN THE CG, NT PRO BNP WAS REDUCED 63.75% IN THE YG AND 10.77% IN THE CG. THE BETWEEN GROUP COMPARISONS FROM PRE TO POST 12 WEEKS WERE SIGNIFICANT FOR YG IMPROVEMENTS (LVEF, P < 0.01, TEI INDEX, P < 0.01, NT PRO BNP, P < 0.01). CONCLUSION: THESE RESULTS INDICATE THAT THE ADDITION OF YOGA THERAPY TO STANDARD MEDICAL THERAPY FOR HF PATIENTS HAS A MARKEDLY BETTER EFFECT ON CARDIAC FUNCTION AND REDUCED MYOCARDIAL STRESS MEASURED USING NT PRO BNP IN PATIENTS WITH STABLE HF. 2014 3 798 42 EFFECT OF YOGA LIFESTYLE IN PATIENTS WITH HEART FAILURE: A RANDOMIZED CONTROL TRIAL. BACKGROUND: IN SPITE OF SIGNIFICANT ADVANCES IN THE MANAGEMENT OF HEART FAILURE (HF), MORBIDITY AND MORTALITY REMAIN HIGH. THEREFORE, THERE IS A NEED FOR ADDITIONAL STRATEGIES. WE DID A RANDOMIZED CLINICAL TRIAL TO STUDY EFFECT OF YOGA IN PATIENTS WITH HF IN TERMS OF QUALITY OF LIFE (QOL), LEFT VENTRICLE EJECTION FRACTION (LVEF), C-REACTIVE PROTEIN (CRP), AND NTPROBNP. MATERIALS AND METHODS: 60 PATIENTS WITH STABLE HF NEW YORK HEART ASSOCIATION CLASS II WITH LVEF 30%-40% WERE RANDOMIZED INTO CONTROL GROUP (CG) AND YOGA GROUP (YG). CG RECEIVED THE GUIDELINE-BASED THERAPY AND YG IN ADDITION PRACTICED THE YOGA, ONE HOUR DAILY FOR 3 MONTHS. ALL PATIENTS WERE ASSESSED FOR QOL, CRP, NTPROBNP, AND LVEF AT BASELINE AND AFTER 3 MONTHS. RESULTS: A SIGNIFICANT DIFFERENCE WAS OBSERVED IN ALL FOUR PARAMETERS IN THE YG AS COMPARED TO THE CG (P < 0.01) AFTER 12 WEEKS. QOL AS ASSESSED BY MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE SCORE IMPROVED SIGNIFICANTLY IN YG AS COMPARED TO CG (10 V/S 14, P < 0.001). THERE WAS A SIGNIFICANT IMPROVEMENT WITHIN YG IN TERMS OF LVEF (33.4-36.8, P = 0.001), AND THE PERCENTAGE CHANGE IN LVEF WAS SIGNIFICANT BETWEEN THE GROUPS (10% V/S 5%, P = 0.001). NTPROBNP ALSO SIGNIFICANTLY REDUCED BY 69.8% FROM 755 TO 220 PMOL/L IN YG AS COMPARED TO 39.3% IN CG (679-406 PMOL/L). CRP DECREASED BY 49.3% (5.36-2.73 MG/L) IN YG AND 35.8% (5.39-3.45 MG/L) IN CG. CONCLUSION: THE RESULT OF THIS PILOT STUDY SUGGESTS THAT ADDITION OF YOGA TO GUIDELINE-BASED THERAPY FOR HF PATIENTS SIGNIFICANTLY IMPROVES QOL, LVEF, AND NTPROBNP AND REDUCES CRP LEVEL. LARGER STUDIES ARE NEEDED TO CONFIRM THESE FINDINGS. 2022 4 873 39 EFFECT OF YOGA THERAPY ON HEART RATE, BLOOD PRESSURE AND CARDIAC AUTONOMIC FUNCTION IN HEART FAILURE. BACKGROUND AND OBJECTIVE: IT IS WELL KNOWN THAT A HALL MARK OF HEART FAILURE IS ADVERSE CHANGES IN AUTONOMIC FUNCTION. ELEVATED BLOOD PRESSURE IS A POWERFUL PREDICTOR OF CONGESTIVE HEART FAILURE AND OTHER CARDIOVASCULAR DISEASE (CVD) OUTCOMES. IN THIS STUDY, WE PLANNED TO EXAMINE THE EFFECTS OF A 12 WEEK YOGA THERAPY ON BLOOD PRESSURE, HEART RATE, HEART RATE VARIABILITY, AND RATE PRESSURE PRODUCT (RPP). METHODS: OUT OF 130 HEART FAILURE PATIENTS RECRUITED FOR THE STUDY, 65 PATIENTS WERE RANDOMLY SELECTED TO RECEIVE 12 WEEK YOGA THERAPY ALONG WITH STANDARD MEDICAL THERAPY (YOGA GROUP). OTHER PATIENTS (N=65) RECEIVED ONLY STANDARD MEDICAL THERAPY (CONTROL GROUP). HEART RATE, BLOOD PRESSURE, CARDIAC AUTONOMIC FUNCTION (BY SHORT-TERM HEART-RATE VARIABILITY ANALYSIS) AND MYOCARDIAL OXYGEN CONSUMPTION (BY RPP) WERE ASSESSED BEFORE AND AFTER 12 WEEKS. IN THE YOGA GROUP, 44 PATIENTS AND IN THE CONTROL GROUP, 48 PATIENTS COMPLETED THE STUDY. RESULTS: THERE WAS A SIGNIFICANT DECREASE IN HEART RATE, BLOOD PRESSURE AND RPP IN YOGA GROUP COMPARED TO CONTROL GROUP. ALSO, LFNU AND LF-HF RATIO DECREASED SIGNIFICANTLY AND HFNU INCREASED SIGNIFICANTLY IN YOGA GROUP COMPARED TO CONTROL GROUP. CONCLUSION: TWELVE-WEEK YOGA THERAPY SIGNIFICANTLY IMPROVED THE PARASYMPATHETIC ACTIVITY AND DECREASED THE SYMPATHETIC ACTIVITY IN HEART FAILURE PATIENTS (NYHA I&II). 2014 5 807 44 EFFECT OF YOGA ON ARRHYTHMIA BURDEN, ANXIETY, DEPRESSION, AND QUALITY OF LIFE IN PAROXYSMAL ATRIAL FIBRILLATION: THE YOGA MY HEART STUDY. OBJECTIVES: THE PURPOSE OF THIS STUDY WAS TO EXAMINE THE IMPACT OF YOGA ON ATRIAL FIBRILLATION (AF) BURDEN, QUALITY OF LIFE (QOL), DEPRESSION, AND ANXIETY SCORES. BACKGROUND: YOGA IS KNOWN TO HAVE SIGNIFICANT BENEFIT ON CARDIOVASCULAR HEALTH. THE EFFECT OF YOGA IN REDUCING AF BURDEN IS UNKNOWN. METHODS: THIS SINGLE-CENTER, PRE-POST STUDY ENROLLED PATIENTS WITH SYMPTOMATIC PAROXYSMAL AF WITH AN INITIAL 3-MONTH NONINTERVENTIONAL OBSERVATION PERIOD FOLLOWED BY TWICE-WEEKLY 60-MIN YOGA TRAINING FOR NEXT 3 MONTHS. AF EPISODES DURING THE CONTROL AND STUDY PERIODS AS WELL AS SF-36, ZUNG SELF-RATED ANXIETY, AND ZUNG SELF-RATED DEPRESSION SCORES AT BASELINE, BEFORE, AND AFTER THE STUDY PHASE WERE ASSESSED. RESULTS: YOGA TRAINING REDUCED SYMPTOMATIC AF EPISODES (3.8 +/- 3 VS. 2.1 +/- 2.6, P < 0.001), SYMPTOMATIC NON-AF EPISODES (2.9 +/- 3.4 VS. 1.4 +/- 2.0; P < 0.001), ASYMPTOMATIC AF EPISODES (0.12 +/- 0.44 VS. 0.04 +/- 0.20; P < 0.001), AND DEPRESSION AND ANXIETY (P < 0.001), AND IMPROVED THE QOL PARAMETERS OF PHYSICAL FUNCTIONING, GENERAL HEALTH, VITALITY, SOCIAL FUNCTIONING, AND MENTAL HEALTH DOMAINS ON SF-36 (P = 0.017, P < 0.001, P < 0.001, P = 0.019, AND P < 0.001, RESPECTIVELY). THERE WAS SIGNIFICANT DECREASE IN HEART RATE, AND SYSTOLIC AND DIASTOLIC BLOOD PRESSURE BEFORE AND AFTER YOGA (P < 0.001). CONCLUSIONS: IN PATIENTS WITH PAROXYSMAL AF, YOGA IMPROVES SYMPTOMS, ARRHYTHMIA BURDEN, HEART RATE, BLOOD PRESSURE, ANXIETY AND DEPRESSION SCORES, AND SEVERAL DOMAINS OF QOL. 2013 6 1039 58 EFFECTS OF YOGA IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION - A RANDOMIZED CONTROLLED STUDY. BACKGROUND: PATIENTS WITH ATRIAL FIBRILLATION OFTEN HAVE AN IMPAIRED QUALITY OF LIFE (QOL). PRACTISING YOGA MAY DECREASE STRESS AND HAVE POSITIVE EFFECTS ON MENTAL AND PHYSICAL HEALTH. THE AIM OF THIS STUDY WAS TO INVESTIGATE WHETHER YOGA CAN IMPROVE QOL AND DECREASE BLOOD PRESSURE AND HEART RATE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION (PAF). METHODS: IN THIS PILOT STUDY, 80 PATIENTS DIAGNOSED WITH PAF WERE RANDOMIZED TO STANDARD TREATMENT (CONTROL GROUP, N=40) OR STANDARD TREATMENT IN COMBINATION WITH YOGA (YOGA GROUP, N=40) DURING A 12-WEEK PERIOD. QOL, BLOOD PRESSURE AND HEART RATE WERE EVALUATED AT BASELINE AND AT THE END OF THE STUDY (12 (+2) WEEKS). EUROQOL-5D (EQ-5D) VISUAL ANALOGUE SCALE (VAS) AND THE TWO DIMENSIONS IN SHORT-FORM HEALTH SURVEY (SF-36) WERE USED TO EVALUATE QOL. RESULTS: AT BASELINE THERE WAS A SIGNIFICANT DIFFERENCE IN QOL BETWEEN THE GROUPS IN EQ-5D VAS- SCALE ( P=0.02) AND SF-36 MENTAL HEALTH SCORE ( P<0.001) IN WHICH THE CONTROL GROUP HAD HIGHER SCORES. AT THE END OF THE STUDY, THE YOGA GROUP AVERAGED HIGHER SF-36 MENTAL HEALTH SCORES. THERE WAS A SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS ( P=0.016), BUT NO DIFFERENCES IN EQ-5D VAS- SCALE AND PHYSIOLOGICAL HEALTH SCORE WAS SEEN BETWEEN THE TWO GROUPS. AT THE END OF THE STUDY, THE YOGA GROUP HAD SIGNIFICANTLY LOWER HEART RATE ( P=0.024) AND SYSTOLIC ( P=0.033) AND DIASTOLIC BLOOD PRESSURE ( P<0.001) COMPARED TO THE CONTROL GROUP. CONCLUSIONS: YOGA WITH LIGHT MOVEMENTS AND DEEP BREATHING MAY LEAD TO IMPROVED QOL, LOWER BLOOD PRESSURE AND LOWER HEART RATE IN PATIENTS WITH PAF COMPARED TO A CONTROL GROUP. YOGA COULD BE A COMPLEMENTARY TREATMENT METHOD TO STANDARD THERAPY. 2017 7 812 25 EFFECT OF YOGA ON CARDIAC AUTONOMIC DYSFUNCTION AND INSULIN RESISTANCE IN NON-DIABETIC OFFSPRING OF TYPE-2-DIABETES PARENTS: A RANDOMIZED CONTROLLED STUDY. OBJECTIVE: THE PRESENT STUDY WAS AIMED TO DETERMINE THE EFFECT OF YOGA PROGRAM ON CARDIAC AUTONOMIC DYSFUNCTION AND INSULIN RESISTANCE IN NON-DIABETIC OFFSPRING OF DIABETES PARENTS. METHODS: A RANDOMIZED PASSIVE-CONTROLLED STUDY WAS CONDUCTED ON 64 NON-DIABETIC OFFSPRING OF TYPE-2-DIABETES PARENTS (MEAN-AGE:25.17YEARS). YOGA GROUP PARTICIPANTS RECEIVED YOGA TRAINING FOR 8 WEEKS. HEART-RATE VARIABILITY (HRV) INDICES: LOW FREQUENCY (LF), HIGH FREQUENCY (HF) AND LF/HF RATIO; FASTING BLOOD GLUCOSE (FBG), ORAL GLUCOSE TOLERANCE TEST (OGTT) AND INSULIN RESISTANCE (IR) WERE ESTIMATED AT BASELINE AND AFTER 8-WEEKS OF INTERVENTION. RESULTS: WE FOUND A SIGNIFICANT DECREASE IN LF (P=0.005), LF/HF RATIO (P=0.004), IR (P<0.001), OGTT (P=0.003) AND INCREASE IN HF (P=0.022) IN YOGA GROUP PARTICIPANTS. CONTROL GROUP PARTICIPANTS DID NOT SHOW ANY SIGNIFICANT CHANGE IN ANY VARIABLES. CONCLUSIONS: IMPROVEMENT IN CARDIAC AUTONOMIC FUNCTION AND INSULIN RESISTANCE BY YOGA TRAINING IMPLIES THAT YOGA CAN REDUCE THE RISK OF DEVELOPMENT OF DIABETES IN OFFSPRING OF DIABETES PARENTS. 2019 8 389 40 BENEFITS OF YOGA FOR AFRICAN AMERICAN HEART FAILURE PATIENTS. BACKGROUND: THE NUMBER OF AFRICAN AMERICAN (AA) PATIENTS LIVING WITH HEART FAILURE (HF) HAS BEEN INCREASING, ESPECIALLY AMONG THE ECONOMICALLY DISADVANTAGED. YOGA THERAPY HAS BEEN FOUND TO IMPROVE PHYSICAL AND PSYCHOLOGICAL PARAMETERS AMONG HEALTHY INDIVIDUALS, BUT ITS EFFECT IN PATIENTS WITH HF REMAINS UNKNOWN. THE PURPOSE OF THIS STUDY WAS TO EXAMINE THE EFFECTS OF YOGA THERAPY ON CARDIOVASCULAR ENDURANCE (VO2PEAK), FLEXIBILITY, QUALITY OF LIFE (QOL), AND INFLAMMATORY MARKERS ON MEDICALLY STABLE HF PATIENTS. METHODS: FORTY PATIENTS (38 AA, 1 ASIAN, AND 1 CAUCASIAN) WITH SYSTOLIC OR DIASTOLIC HF WERE RANDOMIZED TO THE YOGA GROUP (YG, N = 21) OR THE CONTROL GROUP (CG, N = 19). ALL PATIENTS WERE ASKED TO FOLLOW A HOME WALK PROGRAM. PREMEASUREMENT AND POSTMEASUREMENT INCLUDED A TREADMILL STRESS TEST TO PEAK EXERTION, FLEXIBILITY, INTERLEUKIN-6 (IL-6), C-REACTIVE PROTEIN (CRP), AND EXTRACELLULAR SUPEROXIDE DISMUTASE (EC-SOD). QOL WAS ASSESSED BY THE MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE (MLWHFQ). RESULTS: THE STATISTICAL ANALYSES (ASSESSED BY ANOVA AND T-TESTS) WERE SIGNIFICANT FOR FAVORABLE CHANGES IN THE YG, COMPARED WITH THOSE IN THE CG, FOR FLEXIBILITY (P = 0.012), TREADMILL TIME (P = 0.002), VO2PEAK (P = 0.003), AND THE BIOMARKERS (IL-6, P = 0.004; CRP, P = 0.016; AND EC-SOD, P = 0.012). WITHIN THE YG, PRETEST TO POSTTEST SCORES FOR THE TOTAL (P = 0.02) AND PHYSICAL SUBSCALES (P < 0.001) OF THE MLWHFQ WERE IMPROVED. CONCLUSIONS: YOGA THERAPY OFFERED ADDITIONAL BENEFITS TO THE STANDARD MEDICAL CARE OF PREDOMINANTLY AA HF PATIENTS BY IMPROVING CARDIOVASCULAR ENDURANCE, QOL, INFLAMMATORY MARKERS, AND FLEXIBILITY. 2010 9 989 29 EFFECTS OF HATHA YOGA ON CARDIAC HEMODYNAMIC PARAMETERS AND PHYSICAL CAPACITY IN CARDIAC REHABILITATION PATIENTS. PURPOSE: THE PURPOSE OF THE PRESENT STUDY WAS TO ASSESS THE EFFECT OF HATHA YOGA TRAINING THAT WAS ADDED TO THE STANDARD CARDIAC REHABILITATION (CR) PROGRAM ON THE CARDIAC HEMODYNAMIC PARAMETERS AND PHYSICAL CAPACITY OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (STEMI). METHODS: THE STUDY INCLUDED 70 MALE PATIENTS AGED 45-65 YR WITH STEMI WHO WERE TREATED BY ANGIOPLASTY. PATIENTS WERE RANDOMIZED TO STANDARD CR (CONTROL GROUP) VERSUS STANDARD CR PLUS HATHA YOGA (EXPERIMENTAL GROUP). THE TRAINING PROGRAM LASTED FOR A TOTAL OF 24 D FOR EACH PATIENT, WITH DAY 1 AND DAY 24 USED FOR MEDICAL EXAMINATIONS (ELECTROCARDIOGRAM, SPIROERGOMETRIC SUBMAXIMAL TREADMILL TEST, AND ECHOCARDIOGRAPHY). THE REMAINING 22 D CONSISTED OF THE ACTUAL TRAINING. RESULTS: AFTER THE CR PROGRAM THE SPIROERGOMETRIC STRESS TEST PARAMETERS AND LEFT VENTRICULAR EJECTION FRACTION (LVEF) IMPROVED IN BOTH THE EXPERIMENTAL AND CONTROL GROUPS. THE MOST NOTABLE CHANGES IN ECHOCARDIOGRAPHY PARAMETERS AND PHYSICAL CAPACITY WERE IN THE EXPERIMENTAL GROUP. THE RESULTS SHOWED SIGNIFICANT MAIN EFFECT OVER TIME, A TIME-VERSUS-GROUP INTERACTION IN LVEF, THE DURATION OF THE TEST, AND PEAK OXYGEN UPTAKE, AND A TIME-VERSUS-GROUP INTERACTION IN METABOLIC EQUIVALENTS (METS). WE ALSO NOTED THE IMPROVEMENT OF LEFT VENTRICULAR END-DIASTOLIC DIAMETER, LEFT VENTRICULAR END-SYSTOLIC DIAMETER, AND HEART RATE OVER TIME. CONCLUSION: THE RESULTS REVEALED BETTER EFFECTIVENESS IN THE CR PROGRAM WITH A MODIFIED HATHA YOGA TRAINING PROGRAM. HATHA YOGA TRAINING COULD BE RECOMMENDED AS AN ADJUNCT TO STANDARD CR. 2020 10 2463 28 YOGA AS A THERAPEUTIC INTERVENTION FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. PURPOSE: THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF 12 WEEKS YOGIC INTERVENTION ON BLOOD SUGAR AND LIPID PROFILE IN ELDER WOMEN WITH TYPE 2 DIABETES MELLITUS (T2DM). SUBJECTS AND METHODS: TWENTY ELDERLY (AGE RANGE 55-70 YEARS) T2DM WOMEN WERE DIVIDED INTO TWO GROUPS, NAMELY, YOGIC INTERVENTION GROUP (YIG: N = 10, AGE 64.70 +/- 4.03, BODY MASS INDEX [BMI] 24.26 +/- 3.40) AND CONTROL GROUP (CG: N = 10, AGE 64.40 +/- 4.79, BMI 24.28 +/- 2.36). YIG UNDERWENT YOGA PRACTICE (ASANAS, KRIYAS, PRANAYAMAS) FOR 12 WEEKS (3 SESSIONS/WEEK), WHILE THE CG CONTINUED THEIR USUAL ROUTINE ACTIVITIES. STANDING HEIGHT, BODY WEIGHT, BMI, BLOOD SUGAR, AND LIPID PROFILE WERE MEASURED BEFORE COMMENCEMENT AND AFTER 6 AND 12 WEEKS OF YOGIC INTERVENTION IN BOTH GROUPS. RESULTS: THERE WAS A SIGNIFICANT (P < 0.01) DECREASE IN FASTING PLASMA GLUCOSE, POSTPRANDIAL BLOOD SUGAR, TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND VERY LOW DENSITY LIPOPROTEIN, WITH A SIGNIFICANT (P < 0.01) INCREASE IN HIGH-DENSITY LIPOPROTEIN LEVEL FROM ITS INITIAL VALUE IN YIG, WHILE SHOWING INSIGNIFICANT RESULT IN CG. CONCLUSION: IT CAN BE SAID THAT YOGIC INTERVENTION MAY HAVE THE BENEFICIAL EFFECTS ON BLOOD SUGAR AND LIPID PROFILE IN ELDERLY WOMEN WITH T2DM. 2018 11 791 28 EFFECT OF YOGA EXERCISE THERAPY ON OXIDATIVE STRESS INDICATORS WITH END-STAGE RENAL DISEASE ON HEMODIALYSIS. BACKGROUND: OXIDATIVE STRESS PROMOTES ENDOTHELIAL DYSFUNCTION AND ATHEROSCLEROSIS IN CHRONIC RENAL DISEASE. OBJECTIVES: THIS STUDY INVESTIGATED THE IMPACT OF HATHA YOGA ON OXIDATIVE STRESS INDICATORS AND OXIDANT STATUS, IN PATIENTS WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS. DESIGN: THIS PROSPECTIVE RANDOMIZED STUDY CONSISTED OF 33 ESRD PATIENTS IN THE HATHA YOGA EXERCISE GROUP WHO WERE MATCHED WITH 35 ESRD PATIENTS IN THE CONTROL GROUP. OUTCOME MEASURES: THE OXIDATIVE STRESS INDICATORS (MALONDIALDEHYDE - MDA, PROTEIN OXIDATION - POX, PHOSPHOLIPASE A2 - PLA2 ACTIVITY) AND THE OXIDATIVE STATUS (SUPEROXIDE DISMUTASE (SOD) AND CATALASE ACTIVITIES) WERE DETERMINED IN THE BLOOD SAMPLES TAKEN AT THE PRE-HEMODIALYSIS TREATMENT, AT BASELINE (0 MONTHS) AND AFTER FOUR MONTHS. RESULTS: IN PATIENTS IN THE HATHA YOGA EXERCISE GROUP, LIPID PEROXIDATION, AS INDICATED BY MDA DECREASED BY 4.0% AFTER FOUR MONTHS (P = 0.096). THERE WAS ALSO A SIGNIFICANT REDUCTION IN THE ACTIVITY OF PLA FROM 2.68 +/- 0.02 IU / L TO 2.34 IU / L (- 12.7%; P = 0.010) AND POX FROM 2.28 +/- 0.02 NMOL / MG TO 2.22 +/- 0.01 NMOL / MG (- 22.6%; P = 0.0001). THE ACTIVITY OF SOD SIGNIFICANTLY INCREASED FROM 12.91 +/- 0.17 U / L TO 13.54 +/- 0.15 U / L (4.65%; P = 0.0001) AND CATALASE FROM 79.83 +/- 0.63 U / L TO 80.54 +/- 0.80 U / L (0.90%; P = 0.0001). THERE WAS A SIGNIFICANT CORRELATION BETWEEN THE PRE-HEMODIALYSIS OXIDATIVE STRESS PARAMETERS AT THE ZERO MONTH AND AFTER FOUR MONTHS FOR THE ACTIVITIES OF PLA (R = 0.440), CATALASE (R = 0.872), AND SOD (R = 0.775). CONCLUSIONS: THESE FINDINGS SUGGEST THAT THE HATHA YOGA EXERCISE HAS THERAPEUTIC, PREVENTATIVE, AND PROTECTIVE EFFECTS IN ESRD SUBJECTS, BY DECREASING OXIDATIVE STRESS. 2013 12 1066 36 EFFECTS OF YOGA ON INFLAMMATION AND EXERCISE CAPACITY IN PATIENTS WITH CHRONIC HEART FAILURE. BACKGROUND: DESPITE RECENT ADVANCES IN PHARMACOLOGIC AND DEVICE THERAPY, MORBIDITY AND MORTALITY FROM HEART FAILURE (HF) REMAIN HIGH. YOGA COMBINES PHYSICAL AND BREATHING EXERCISES THAT MAY BENEFIT PATIENTS WITH HF. WE HYPOTHESIZED THAT AN 8-WEEK REGIMEN OF YOGA IN ADDITION TO STANDARD MEDICAL THERAPY WOULD IMPROVE EXERCISE CAPACITY, INFLAMMATORY MARKERS, AND QUALITY OF LIFE (QOL) IN PATIENTS WITH HF. METHODS AND RESULTS: NEW YORK HEART ASSOCIATION CLASS I-III HF PATIENTS WERE RANDOMIZED TO YOGA TREATMENT (YT) OR STANDARD MEDICAL THERAPY (MT). MEASUREMENTS INCLUDED A GRADED EXERCISE TEST (GXT) TO V O(2PEAK) AND THE FOLLOWING SERUM BIOMARKERS: INTERLEUKIN-6 (IL-6), HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP), AND EXTRACELLULAR SUPEROXIDE DISMUTASE (EC-SOD). THE MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE (MLHFQ) WAS ADMINISTERED TO ASSESS CHANGES IN QOL. A TOTAL OF 19 PATIENTS WERE ENROLLED AFTER THE INITIAL SCREENING. OF THE 19 PATIENTS, 9 WERE RANDOMIZED TO YT AND 10 TO MT. PATIENTS HAD A MEAN EF OF 25%. GXT TIME AND V O(2PEAK) WERE SIGNIFICANTLY IMPROVED IN THE YT VERSUS MT GROUPS (+18% IN THE YT AND -7.5% IN MT; P = .03 VS. CONTROL AND +17 IN YT AND -7.1 IN MT; P = .02, RESPECTIVELY). THERE WERE STATISTICALLY SIGNIFICANT REDUCTIONS IN SERUM LEVELS OF IL-6 AND HSCRP AND AN INCREASE IN EC-SOD IN THE YT GROUP (ALL P < .005 VS. MT). MLHFQ SCORES IMPROVED BY 25.7% IN THE YT GROUP AND BY 2.9% IN THE MT GROUP. CONCLUSIONS: YOGA IMPROVED EXERCISE TOLERANCE AND POSITIVELY AFFECTED LEVELS OF INFLAMMATORY MARKERS IN PATIENTS WITH HF, AND THERE WAS ALSO A TREND TOWARD IMPROVEMENTS IN QOL. 2008 13 939 37 EFFECTS OF 12 WEEKS PRACTICE OF YOGA ON HEART RATE VARIABILITY IN MALES WITH TYPE 2 DIABETES RECEIVING ORAL ANTIDIABETIC DRUGS: A RANDOMIZED CONTROL TRIAL. OBJECTIVE: TO INVESTIGATE THE EFFECTS OF 12 WEEKS PRACTICE OF A STRUCTURED YOGA MODULE ON HEART RATE VARIABILITY (HRV) AND CARDIOMETABOLIC RISKS IN PATIENTS WITH TYPE 2 DIABETES (T2D) RECEIVING SIMILAR KIND OF ORAL ANTIDIABETIC DRUGS (OAD) WITH YOGA THERAPY AND WITHOUT YOGA THERAPY, MATCHED FOR ALL THE KNOWN CONFOUNDERS. DESIGN: PARALLEL DESIGN INTERVENTIONAL (RANDOMIZED CONTROL TRIAL) STUDY. SUBJECTS: EIGHTY TREATMENT-NAIVE MALES WITH T2D WERE RANDOMIZED INTO CONTROL GROUP (N = 40) AND STUDY GROUP (N = 40). INTERVENTION: STUDY GROUP PARTICIPANTS RECEIVED A STRUCTURED YOGA THERAPY THAT INCLUDED ASANA AND PRANAYAMA PRACTICE FOR 12 WEEKS IN ADDITION TO OAD, WHEREAS CONTROL GROUP PARTICIPANTS RECEIVED OAD ALONE. OUTCOME MEASURES: BEFORE AND AFTER INTERVENTION, BP PARAMETERS, RATE PRESSURE PRODUCT (RPP) AS THE MARKER OF MYOCARDIAL STRESS, TOTAL POWER (TP) OF HRV, LOW-FREQUENCY TO HIGH-FREQUENCY (LF-HF) RATIO OF HRV, HOMEOSTATIC MODEL OF INSULIN RESISTANCE (HOMA-IR), LIPID PROFILE AND LIPID RISK FACTORS, MALONDIALDEHYDE (MDA), AND HIGH-SENSITIVE C-REACTIVE PROTEIN (HSCRP) WERE MEASURED. TP OF HRV WAS DEFINED AS THE PRIMARY OUTCOME. ASSOCIATION OF TP (THE MARKER OF HRV) AND LF-HF RATIO (THE MARKER OF SYMPATHOVAGAL BALANCE) WITH CARDIOMETABOLIC PARAMETERS WAS ASSESSED BY CORRELATION AND REGRESSION ANALYSES. RESULTS: AFTER 12 WEEKS YOGA THERAPY, THERE WAS SIGNIFICANT REDUCTION IN CARDIOMETABOLIC RISKS (TP OF HRV, RPP, LIPID RISKS FACTORS, LEVELS OF MDA, AND HSCRP) IN STUDY GROUP SUBJECTS COMPARED WITH CONTROL SUBJECTS THAT DID NOT RECEIVE YOGA THERAPY. ALL CARDIOMETABOLIC RISK FACTORS WERE SIGNIFICANTLY CORRELATED WITH TP IN STUDY GROUP, HAVING MAXIMUM SIGNIFICANCE WITH HOMEOSTATIC MODEL OF INSULIN SECRETION (R = 0.502, P /=23) AFTER 12 MONTHS. YOGA GROUP SHOWED SIGNIFICANT (P = 0.008, WILCOXON'S) REDUCTION IN BLOOD GLUCOSE AT ONE YEAR IN THOSE WITH HIGH BASELINE FBS >/=110 MG/DL. THERE WAS SIGNIFICANTLY BETTER IMPROVEMENT IN YOGA THAN THE CONTROL GROUP IN HDL (P = 0.003), LDL (P = 0.01) AND VLDL (P = 0.03) IN THOSE WITH ABNORMAL BASELINE VALUES. THERE WAS SIGNIFICANTLY BETTER IMPROVEMENT (P = 0.02, BETWEEN GROUPS) IN POSITIVE AFFECT IN YOGA GROUP. WITHIN YOGA GROUP, THERE WAS SIGNIFICANT DECREASE IN PERCEIVED STRESS (P = 0.001), ANXIETY (P = 0.001), DEPRESSION (P = 0.001), AND NEGATIVE AFFECT (P = 0.03) WHILE IN THE CONTROL GROUP THERE WAS REDUCTION (P = 0.003) ONLY IN SCORES ON ANXIETY. CONCLUSION: ADDITION OF YOGA BASED RELAXATION TO CONVENTIONAL POST-CABG CARDIAC REHABILITATION HELPS IN BETTER MANAGEMENT OF RISK FACTORS IN THOSE WITH ABNORMAL BASELINE VALUES AND MAY HELP IN PREVENTING RECURRENCE. 2014 20 871 38 EFFECT OF YOGA THERAPY ON DISEASE ACTIVITY, INFLAMMATORY MARKERS, AND HEART RATE VARIABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS. BACKGROUND: RHEUMATOID ARTHRITIS (RA) IS AN IMMUNE-MEDIATED INFLAMMATORY DISEASE. ANTIRHEUMATOID TREATMENT REDUCES DISEASE ACTIVITY AND INFLAMMATION, BUT NOT ALL PATIENTS RESPOND TO TREATMENT. AUTONOMIC DYSFUNCTION IS COMMON IN RA LEADING TO FREQUENT CARDIOVASCULAR COMPLICATIONS. YOGA THERAPY MAY BE USEFUL IN THESE PATIENTS, BUT THERE ARE LITTLE DATA ON THE EFFECT OF YOGA ON DISEASE ACTIVITY, INFLAMMATORY MARKERS, AND HEART RATE VARIABILITY (HRV). OBJECTIVES: THIS STUDY ASSESSED THE EFFECT OF 12-WEEK YOGA THERAPY ON DISEASE ACTIVITY, INFLAMMATORY MARKERS, AND HRV IN PATIENTS WITH RA. MATERIALS AND METHODS: THIS RANDOMIZED CONTROL TRIAL WAS CONDUCTED ON NEWLY DIAGNOSED RA PATIENTS ATTENDING OUTPATIENT SERVICES AT THE DEPARTMENT OF CLINICAL IMMUNOLOGY, JIPMER. ONE HUNDRED AND SIXTY-SIX PARTICIPANTS WERE RANDOMIZED INTO TWO GROUPS: THE CONTROL GROUP (CG) (N = 83) AND YOGA GROUP (YG) (N = 83). YOGA THERAPY WAS ADMINISTERED TO PARTICIPANTS IN THE YG FOR 12 WEEKS, ALONG WITH STANDARD MEDICAL TREATMENT. THE CG RECEIVED ONLY STANDARD MEDICAL TREATMENT. PRIMARY OUTCOMES WERE DISEASE ACTIVITY SCORE 28, INTERLEUKIN-1ALPHA (IL-1ALPHA), IL-6, TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA), CORTISOL, AND HRV PARAMETERS. ALL PARAMETERS WERE MEASURED AT BASELINE AND AFTER 12 WEEKS. RESULTS: DISEASE ACTIVITY SIGNIFICANTLY DECREASED IN BOTH GROUPS AFTER 12 WEEKS, BUT IT WAS REDUCED MORE IN YG, WHICH WAS STATISTICALLY SIGNIFICANT (P < 0.05). IN BOTH YG AND CG, IL-1ALPHA, IL-6, TNF-ALPHA, AND CORTISOL DECREASED AFTER 12 WEEKS, BUT IL-1ALPHA AND CORTISOL DECREASED MORE SIGNIFICANTLY IN YG THAN IN CG. LOW-FREQUENCY COMPONENT EXPRESSED AS NORMALIZED UNIT (LFNU) AND THE LOW-FREQUENCY/HIGH-FREQUENCY (LF-HF) RATIO DECREASED SIGNIFICANTLY, AND TOTAL POWER AND HF COMPONENT EXPRESSED AS NORMALIZED UNIT (HFNU) INCREASED SIGNIFICANTLY IN THE YG COMPARED WITH CG. CONCLUSION: TWELVE-WEEK YOGA THERAPY, IF GIVEN ALONG WITH STANDARD MEDICAL TREATMENT, SIGNIFICANTLY REDUCES DISEASE ACTIVITY AND IMPROVES SYMPATHOVAGAL BALANCE IN RA PATIENTS. 2020